New CEO Envisions A Broader Role For New York Academy

The newly appointed chief executive officer of the New York Academy of Sciences says he hopes to guide the academy to a leadership role in the national and international arenas as well as locally. "One of the academy's central functions must continue to be serving the science and engineering community itself," says Rodney W. Nichols, named to the CEO post late last month. "But the function of serving society, which has always been tacit, really has to rise to equal priority." Nichols, a forme

Written byBarbara Spector
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

Nichols, a former executive vice president of Rockefeller University who since October 1990 has been a scholar-in-residence at the Carnegie Corporation of New York, assumes his post at the 31,000-member academy on April 1. He succeeds Oakes Ames, who resigned last August after less than 2 1/2 years on the job (The Scientist, Sept. 30, 1991, page 3).

The 54-year-old Nichols notes that "New York City is blessed with many research universities and intellectuals in a variety of fields. But they haven't been organized in New York to think about the rest of the country, or even about New York itself."

The new CEO says he hopes to strengthen the academy's role as "a forum for bringing together the people in New York who otherwise would go to Washington" to discuss national and global issues at the National Academy of Sciences or other national forums.

Nichols's experience at focusing on ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies